Omeros reported $-46048000 in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acelrx Pharmaceuticals ACRX:US USD -6739000 1.75M
Alnylam Pharmaceuticals ALNY:US USD -207021000 122.34M
Biomarin Pharmaceutical BMRN:US USD -17558000 15.65M
Cytokinetics CYTK:US USD -137380000 4.93M
Dynavax Technologies DVAX:US USD 67.97M 3.88M
Gilead Sciences GILD:US USD 2.52B 357M
Heron Therapeutics HRTX:US USD -41882000 14.48M
Insmed INSM:US USD -159998000 29.22M
Intercept Pharmaceuticals ICPT:US USD -17543000 86.54M
Knight Therapeutics Inc GUD:CN CAD -23135000 23.99M
Macrogenics MGNX:US USD 12.8M 37.61M
Mirati Therapeutics MRTX:US USD -202221000 28.91M
Omeros OMER:US USD -46048000 8.74M
Pacira Pharmaceuticals PCRX:US USD 46.48M 4.25M
Pfizer PFE:US USD 7.38B 3.3B
Regulus Therapeutics RGLS:US USD -6795000 756K
Rockwell Medical RMTI:US USD -4190000 777K
Sangamo Biosciences SGMO:US USD -51714000 1.41M
Sarepta Therapeutics SRPT:US USD -101306000 155.11M
United Therapeutics UTHR:US USD 178.8M 133.7M
Vertex Pharmaceuticals VRTX:US USD 1.2B 122.8M
Vital Therapies VTL:US USD -56474000 35.25M
Xoma XOMA:US USD -5894000 1.72M